Dashboard
1
Poor Management Efficiency with a low ROCE of 0%
- The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2
Poor long term growth as Net Sales has grown by an annual rate of -9.68% and Operating profit at 2.96% over the last 5 years
3
With a growth in Net Sales of 4594.65%, the company declared Very Positive results in Dec 25
4
Risky -
5
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
CNY 2,110 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.98
-19.83%
3.10
Revenue and Profits:
Net Sales:
7 Million
(Quarterly Results - Dec 2025)
Net Profit:
26 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.86%
0%
-2.86%
6 Months
-21.06%
0%
-21.06%
1 Year
17.94%
0%
17.94%
2 Years
-24.35%
0%
-24.35%
3 Years
-17.14%
0%
-17.14%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Shouyao Holdings (Beijing) Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-9.68%
EBIT Growth (5y)
2.96%
EBIT to Interest (avg)
-215.69
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.93
Sales to Capital Employed (avg)
0.01
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
9.22
EV to EBIT
-24.19
EV to EBITDA
-24.93
EV to Capital Employed
171.90
EV to Sales
2753.85
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-710.66%
ROE (Latest)
-31.97%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
6.70
0.10
6,600.00%
Operating Profit (PBDIT) excl Other Income
25.70
-61.50
141.79%
Interest
0.00
0.10
-100.00%
Exceptional Items
0.00
3.30
-100.00%
Consolidate Net Profit
25.90
-52.00
149.81%
Operating Profit Margin (Excl OI)
3,851.90%
-445,342.50%
44,919.44%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 6,600.00% vs -50.00% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 149.81% vs -5.05% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
8.70
3.90
123.08%
Operating Profit (PBDIT) excl Other Income
-129.50
-224.50
42.32%
Interest
0.00
0.20
-100.00%
Exceptional Items
0.00
3.40
-100.00%
Consolidate Net Profit
-128.80
-211.90
39.22%
Operating Profit Margin (Excl OI)
-14,937.80%
-58,774.90%
4,383.71%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 123.08% vs -25.00% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 39.22% vs -14.17% in Dec 2024
About Shouyao Holdings (Beijing) Co. Ltd. 
Shouyao Holdings (Beijing) Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






